PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Nanomater S.r.l., Alghero, 07041, Italy.\', \'Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, United States.\', \'Department of Medical, Surgical and Experimental Sciences, Laboratory of Drug Design and Nanomedicine, University of Sassari, Sassari, 07100, Italy. Electronic address: mario.sechi@uniss.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0223-5234(22)00023-X10.1016/j.ejmech.2022.114121
?:doi
?:hasPublicationType
?:journal
  • European journal of medicinal chemistry
is ?:pmid of
?:pmid
?:pmid
  • 35114539
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.266
?:rankingScore_hIndex
  • 127
is ?:relation_isRelatedTo_publication of
?:title
  • Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35114539>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35114539>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all